Contraceptive Efficacy
- 1 September 1995
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 131 (9) , 1064-1068
- https://doi.org/10.1001/archderm.1995.01690210094016
Abstract
Will it work?'' is the question usually asked first and most frequently about any contraceptive method. This question is especially salient for women using teratogenic drugs and their clinicians, particularly dermatologists. As discussed in other articles in this issue of the Archives, dermatologists prescribe two of the most potent teratogenic drugs, isotretinoin (Accutane, Roche Laboratories, Nutley, NJ) and thalidomide.1,2 Because this question cannot be answered with certainty for any particular couple, most clinicians and counselors try to help patients understand factors influencing contraceptive efficacy.This publication has 7 references indexed in Scilit:
- Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis. Results of an open, pilot trialArchives of Dermatology, 1995
- Contraceptive efficacy and acceptability of the female condom.American Journal of Public Health, 1994
- A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraceptionHuman Reproduction, 1993
- Intrauterine devices and pelvic inflammatory disease: an international perspectiveThe Lancet, 1992
- Effectiveness of IUDs: A reviewContraception, 1987
- Parity and use-effectiveness with the contraceptive spongeAmerican Journal of Obstetrics and Gynecology, 1986
- Age and InfertilityScience, 1986